Drug name - Gvoke Hypopen

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9649364 XERIS Methods for producing stable therapeutic formulations in aprotic polar solvents Apr, 2036

(13 years from now)

Drugs and Companies using GLUCAGON ingredient

Treatment: Treatment of severe hypoglycemia

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
0.5MG/0.1ML (0.5MG/0.1ML) SOLUTION;SUBCUTANEOUS Prescription
1MG/0.2ML (1MG/0.2ML) SOLUTION;SUBCUTANEOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.